We all want to keep our communities safe from chemicals that can pose a threat to the health of our constituents. However, we need to get the solution right and not settle on a one-size-fits-all approach. As currently written, the PFAS…
Larry Bucshon
The Public Record
Larry Bucshon is an American politician and physician serving as the U.S. Representative for Indiana's 8th congressional district since 2011. A member of the Republican Party, Bucshon has focused on healthcare policy, leveraging his medical background to inform his legislative priorities. He has been involved in various initiatives aimed at improving healthcare access and affordability for his constituents. Bucshon has also participated in discussions surrounding fiscal responsibility and economic growth in Indiana.
Well, because it has not been shown to be toxic. It has been approved by the FDA and shown to be safe for patient use. And we might not be able to use them in the future if it is declared toxic.
House Democrats have been obsessed with impeaching President Trump since he was elected. He wasn't supposed to win. ``How could the voters support him?'' they asked. The American people were told the only way the Speaker would move forward…
There are over 150 medical device companies in the State of Indiana representing more than 20,000 jobs. These are high-paying, stable jobs, with more than $1 billion in Indiana payrolls. But, more importantly, they provide lifesaving…
I am proud to colead the U.S. SAFE WEB Extension Act with Ranking Member McMorris Rodgers, Chairwoman Schakowsky, and Congresswoman Kelly.
First off, I want to thank you for your recent proposal to reform Stark Law.
if the Federal Government gets more into this space, which is being proposed in H.R. 3, is that you will indeed have financial decisions being made by different administrations that may very well limit access based on the Government's…
One of the risks of doing the wrong thing in the U.S. on drug pricing can, in my view, severely limit potential access to medication.
I was a heart surgeon before I was in Congress, and for me the key is patient access to affordable healthcare.
The U.S. Federal Government, potentially, in the negotiations could make policy decisions that are essentially medical decisions on who gets access and who doesn't based on cost.
I would implore us to bring bipartisan bills passed unanimously out of this committee to bring down drug prices to the floor for a vote.
It is kind of clear to me, at least at the leadership level on the majority side, that there may not be much interest in actually getting something signed into law but to play politics primarily against the President.





